Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis-Reference-Cited by-同舟云学术

Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis

Published:2021-05-17 Issue:9 Volume:25 Page:1035-1046
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Sugiyama Naoya,Tawada Mitsuhiro,Sun Ting,Suzuki Yasuhiro,Kinashi Hiroshi,Yamaguchi Makoto,Katsuno Takayuki,Aten Jan,Vlahu Carmen A.,van Kuppevelt Toin H.,Takei Yoshifumi,Ishimoto Takuji,Maruyama Shoichi,Mizuno Masashi,Ito Yasuhiko^ORCID

Funder

Ministry of Education

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10157-021-02078-9.pdf

Reference45 articles.

1. Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int. 2000;20(4_suppl):22–42.

2. Garcia-Lopez E, Lindholm B, Davies S. An update on peritoneal dialysis solutions. Nat Rev Nephrol. 2012;8(4):224–33.

3. Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21(7):1077–85.

4. Perl J, Nessim SJ, Bargman JM. The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Kidney Int. 2011;79(8):814–24.

5. Yohanna S, Alkatheeri AM, Brimble SK, McCormick B, Iansavitchous A, Blake PG, et al. Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2015;10(8):1380–8.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysis;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2024-08-28

2. Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis;International Journal of Molecular Sciences;2024-08-07

3. Selective therapeutic efficacy of tyrosine kinase inhibitor sorafenib on the restoration of methylglyoxal-induced peritoneal fibrosis;Biomedicine & Pharmacotherapy;2024-07

4. Role of endothelial hyaluronan in peritoneal membrane transport and disease conditions during peritoneal dialysis;Scientific Reports;2024-03-28

5. Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge;International Journal of Molecular Sciences;2024-03-20